Mar 1, 2023 · This study provides large-scale validation that CCNE1 high-level amplification is associated with shorter survival, supporting its utility as a prognostic ...
Dec 26, 2022 · Here, our objectives were to validate previously reported associations of CCNE1 alterations with overall survival; assess correlations between ...
Mar 1, 2023 · Background: Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HGSC).
Mar 1, 2023 · CCNE1 high-level amplification and overexpression both were linked to shorter overall survival in multivariate survival analysis adjusted for ...
The hypothesis was that high-level amplification of CCNE1 and CCNE1 overexpression, as well as a combination of the two, are linked to shorter overall survival ...
"CCNE1 and survival of patients with tubo- ovarian high- grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study." Cancer 129(5): 697-713.
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. 2023. Kang, Eun‐Young;; Weir ...
The hypothesis was that high-level amplification of CCNE1 and CCNE1 overexpression, as well as a combination of the two, are linked to shorter overall survival ...
Mar 1, 2023 · Dive into the research topics of 'CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis ...
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: an Ovarian Tumor. Tissue Analysis consortium study. Running title: CCNE1 in ...
